Events|

SHL to exhibit at BIO International Convention 2019

Press Release News 201905 Bio 2019
Press Release News 201905 Bio 2019

SHL Group is exhibiting at the 2019 BIO International Convention in Philadelphia, Pennsylvania, USA from June 3-6.

SHL will showcase its vast portfolio of drug delivery systems designed to accommodate a wide range of drugs and biologics in a variety of volumes and viscosities. SHL representatives will also introduce its vertically integrated solutions for device development programs, including precision design and engineering capabilities, turnkey solutions for final assembly, labeling, and packaging, as well analytical testing solutions for both sub-assemblies and fully assembled combination products.

This will mark SHL’s third year participating in the annual event. Business Development Director, Taras Seniuch, commented: “SHL understands the intricacies of the self-injection process and the complexities of combination product development timelines. SHL combines years of knowledge and experience with a strong set of in-house capabilities to help our partners ensure the successful commercialization of their combination product in a timely manner. We’re excited to meet with our partners from across the biotech industry to learn how we can further support their drug development programs.”

Bio International attracts more than 16,000 industry leaders from over 7,000 companies worldwide and it is the largest global networking and exhibiting event for the biotechnology industry.

To learn more, visit SHL at Booth 2455 at the Pennsylvania Convention Center.

About SHL Medical

As a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by our company purpose – Enabling Patients’ Independence – we offer patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. We also offer final assembly, labeling, and packaging solutions for our drug delivery systems.  ​

In response to the rising trend in home therapy, SHL has increased developmental work in the digital healthcare sector to help improve the drug delivery ecosystem

Located across Switzerland, Taiwan, Sweden, and the US, our global team of experts collaborate seamlessly as one team in utilizing our comprehensive in-house manufacturing capabilities. Our solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into our designs and processes to contribute to a cleaner earth.​

For additional information, visit www.shl-medical.com

Media contact: info@shl-medical.com

Share:

Related News